Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Erik Renström

Erik Renström


Erik Renström

CaV2.3 calcium channels control second-phase insulin release.


  • Xingjun Jing
  • Dai-Qing Li
  • Charlotta Olofsson
  • Albert Salehi
  • Vikas Surve
  • José Caballero
  • Rosita Ivarsson
  • Ingmar Lundquist
  • Alexey Pereverzev
  • Toni Schneider
  • Patrik Rorsman
  • Erik Renström

Summary, in English

Concerted activation of different voltage-gated Ca2+ channel isoforms may determine the kinetics of insulin release from pancreatic islets. Here we have elucidated the role of R-type CaV2.3 channels in that process. A 20% reduction in glucose-evoked insulin secretion was observed in CaV2.3-knockout (CaV2.3–/–) islets, close to the 17% inhibition by the R-type blocker SNX482 but much less than the 77% inhibition produced by the L-type Ca2+ channel antagonist isradipine. Dynamic insulin-release measurements revealed that genetic or pharmacological CaV2.3 ablation strongly suppressed second-phase secretion, whereas first-phase secretion was unaffected, a result also observed in vivo. Suppression of the second phase coincided with an 18% reduction in oscillatory Ca2+ signaling and a 25% reduction in granule recruitment after completion of the initial exocytotic burst in single CaV2.3–/– ß cells. CaV2.3 ablation also impaired glucose-mediated suppression of glucagon secretion in isolated islets (27% versus 58% in WT), an effect associated with coexpression of insulin and glucagon in a fraction of the islet cells in the CaV2.3–/– mouse. We propose a specific role for CaV2.3 Ca2+ channels in second-phase insulin release, that of mediating the Ca2+ entry needed for replenishment of the releasable pool of granules as well as islet cell differentiation.


  • Diabetes - Islet Patophysiology
  • Department of Experimental Medical Science
  • Vascular Physiology
  • Department of Clinical Sciences, Malmö

Publishing year







Journal of Clinical Investigation





Document type

Journal article


Am Soc Clin Investig


  • Endocrinology and Diabetes



Research group

  • Diabetes - Islet Patophysiology
  • Vascular Physiology


  • ISSN: 0021-9738